Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting

• Catherine B. JohannesRTI Health Solutions
• Daniel C. BeachlerCarelon Research (United States)
• J. Bradley LaytonRTI Health Solutions
• Heather E. DanyshRTI Health Solutions
• RYAN M. ZIEMIECKIRTI Health Solutions
• Alejandro AranaRTI Health Solutions
• Jade DinhCarelon Research (United States)
• Ling LiRTI Health Solutions
• Brian CalingaertRTI Health Solutions
• Manel PladevallHenry Ford Health
• Phillip R. HuntAstraZeneca (United States)
• Hungta ChenAstraZeneca (United States)
• Cecilia KarlssonAstraZeneca (Sweden)
• Kristina M. JohnssonAstraZeneca (Sweden)
• Alicia GilsenanRTI Health Solutions